Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high21.00 08/08/16
52 week low12.80 28/09/15
52 week change 2.50 (16.81%)
4 week volume1,591,889 30/08/16

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
07/07/2015
Presenter: Kieron Harbinson, Group Finance Director
15/04/2015

Latest NewsMore

Result of AGM

Notification of the result of any voting at an AGM

Omega Diagnostics secures £1.8m R&D grant

Omega Diagnostics has secured a Scottish Enterprise research and development grant of 1.8m. This represented a significan...

R&D Grant Funding

Miscellaneous medium priority announcements

Holding(s) in Company

Notification of major interests in shares

Holding(s) in Company

Notification of major interests in shares

Omega pre-tax profit down to £1.35m

Medical diagnostics firm Omega (ODX) said its full year pre-tax profit dropped from 1.37 million to 1.35 million. Omega is ...

Final Results

Announcement of full year/4th quarter financial results

Holding(s) in Company

Notification of major interests in shares

Fundamental DataMore

P/E ratio34.75
EPS0.5
Dividend yield0 %

Equity Research (ODX)

edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...
edison investment research
Omega Diagnostics Group PLC
07/12/2015
H1 results (30 November 2015) noted that the Allersys allergy system could launch in spring 2016, with 37 optimised assays out of 40 targeted for launch. Omega’s Visitect CD4 test to monitor HIV...

Latest discussion posts More

  • Re: RNS today re #1.8m grant win!

    This is indeed a huge grant when compared to some NGOs recent grants but more importantly highlights external confidence in the company and its product line.
    2-Aug-2016
    The Specialist
  • Re: RNS today re #1.8m grant win!

    Great news which allows them to develop their Allergens business in an accelerated fashion and once CD4 passes field tests done funds could be used to accelerate productions. ...
    2-Aug-2016
    The Specialist
  • RNS today re #1.8m grant win!

    Wow - RNS today for ODX's receipt of a #1.8m grant towards Allersys ...
    2-Aug-2016
    gretel

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.33%
IQE22%
SAINSBURY(J)22%
BARCLAYS16%
BP16%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX